Shell Asset Management CO Bio Rad Laboratories, Inc. Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 271 shares of BIO stock, worth $92,549. This represents 0.0% of its overall portfolio holdings.

Number of Shares

271

Previous 287 5.57%

Holding current value

$92,549

Previous $78,000 16.67%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$263.97 - $344.64 $4,223 - $5,514	-16 Reduced 5.57%	271 $91,000
Q1 2024 Jul 31, 2024	SELL	$304.11 - $351.99 $5,473 - $6,335	-18 Reduced 5.9%	287 $78,000
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $3,953 - $4,575	-13 Reduced 4.09%	305 $105,000
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $25,320 - $34,313	-94 Reduced 22.82%	318 $103,000
Q3 2023 Nov 08, 2023	SELL	$350.25 - $422.63 $2,101 - $2,535	-6 Reduced 1.44%	412 $148,000
Q2 2023 Jul 28, 2023	SELL	$359.49 - $486.4 $111,801 - $151,270	-311 Reduced 42.66%	418 $158,000
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $418 - $503	-1 Reduced 0.14%	729 $349,000
Q4 2022 Feb 07, 2023	SELL	$351.71 - $456.01 $55,218 - $71,593	-157 Reduced 17.7%	730 $307,000
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $96,133 - $131,239	-233 Reduced 20.8%	887 $370,000
Q2 2022 Aug 09, 2022	BUY	$463.67 - $597.16 $463 - $597	1 Added 0.09%	1,120 $554,000
Q1 2022 May 04, 2022	SELL	$524.57 - $735.42 $88,127 - $123,550	-168 Reduced 13.05%	1,119 $630,000
Q4 2021 Feb 09, 2022	SELL	$708.84 - $794.68 $708 - $794	-1 Reduced 0.08%	1,287 $972,000
Q3 2021 Nov 04, 2021	SELL	$657.71 - $825.77 $434,088 - $545,008	-660 Reduced 33.88%	1,288 $961,000
Q2 2021 Aug 12, 2021	BUY	$576.64 - $649.04 $428,443 - $482,236	743 Added 61.66%	1,948 $1.26 Million
Q1 2021 May 10, 2021	SELL	$547.01 - $662.35 $482,462 - $584,192	-882 Reduced 42.26%	1,205 $688,000
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $283,938 - $357,758	-556 Reduced 21.04%	2,087 $1.22 Million
Q2 2020 Aug 10, 2020	SELL	$334.87 - $493.06 $430,977 - $634,568	-1,287 Reduced 32.75%	2,643 $1.19 Million
Q1 2020 May 11, 2020	SELL	$320.01 - $409.07 $11,520 - $14,726	-36 Reduced 0.91%	3,930 $1.38 Million
Q4 2019 Feb 13, 2020	BUY	$319.73 - $374.2 $22,381 - $26,194	70 Added 1.8%	3,966 $1.47 Million
Q3 2019 Nov 12, 2019	SELL	$304.55 - $345.24 $6,395 - $7,250	-21 Reduced 0.54%	3,896 $1.3 Million
Q2 2019 Aug 12, 2019	SELL	$286.93 - $312.59 $16,355 - $17,817	-57 Reduced 1.43%	3,917 $1.22 Million
Q1 2019 May 09, 2019	BUY	$224.3 - $317.41 $164,636 - $232,978	734 Added 22.65%	3,974 $1.22 Million
Q4 2018 Feb 13, 2019	SELL	$220.1 - $309.0 $193,688 - $271,920	-880 Reduced 21.36%	3,240 $752,000
Q3 2018 Nov 13, 2018	BUY	$289.28 - $326.15 $798,412 - $900,173	2,760 Added 202.94%	4,120 $1.29 Million
Q2 2018 Aug 10, 2018	BUY	$244.1 - $303.88 $331,976 - $413,276	1,360 New	1,360 $392,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Bio Rad Laboratories, Inc. Transaction History